Myeloma UK has partnered with the UK Myeloma Society (UKMS), formerly the UK Myeloma Forum, to develop a digital infosession to promote best practice in the implementation and management of treatments.

This bitesize ‘after-work’ session for all healthcare professionals will be hosted on Zoom. You will hear from UKMS medical, nursing, and pharmacy experts sharing their knowledge and insights on the innovation journey.

The first infosession, entitled ‘BCMA and GPRC5D Antibodies in Practice: Implementation and management for healthcare professionals’, will be led by Dr Rakesh Popat, Consultant Haematologist and Associate Professor at the University College London Hospitals NHS Foundation Trust.

Rakesh will be joined by guests Elaine Bell, Myeloma and Amyloidosis Clinical Nurse Specialist from the University College London Hospitals NHS Foundation Trust, and Baguiasri Mandane, Specialist Pharmacist in Haematology, Oncology and Aseptic Services from King’s College Hospital NHS Foundation Trust.

The panel will focus on how to set up and deliver anti-BCMA and GPRC5D antibody treatments and how to manage best the care of patients receiving these antibodies.

Myeloma cells have a higher level of BCMA and GPRC5D proteins on their surface. They are promising markers for targeting myeloma cells.

The free webinar takes place on Wednesday, 19 April, from 5-6pm. Register, and you will receive details on how to join the session.

We will round off the webinar with the opportunity to ask the speakers questions.